IP Library Granted Patent US 10,363,246
Granted Patent B1
US 10,363,246 · App. 16/356,517 · Granted Jul 30, 2019

Methods and compositions for treatment of epileptic disorders

Inventor: Matthew During (Weston, CT)
Assignee: Ovid Therapeutics Inc.
A61K31/437A61K9/0019A61K31/165A61K31/19A61K31/195A61K31/197A61K31/27A61K31/325A61K31/36A61K31/4015A61K31/4166A61K31/4192A61K31/423A61K31/433A61K31/44A61K31/444A61K31/4535A61K31/513A61K31/515A61K31/53A61K31/55A61K31/5513A61K31/5517A61K31/57A61K31/7048A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,363,246
App. No.
16/356,517
Granted
Jul 30, 2019
Kind
B1
Abstract

Use of allosteric modulators and/or gaboxadol for the treatment of epileptic disorders in a subject in need thereof.

Claims (5)

1. A method of treating essential tremor comprising administering to a patient in need thereof a pharmaceutical composition comprising gaboxadol or a pharmaceutically acceptable salt thereof.

2. The method of claim 1 , wherein the patient is administered a composition comprising about 0.05 mg to about 30 mg gaboxadol or a pharmaceutically acceptable salt thereof.

3. The method of claim 1 , wherein the patient is administered a composition comprising about 1 mg to about 15 mg gaboxadol or a pharmaceutically acceptable salt thereof.

4. The method of claim 1 , wherein the patient is administered a composition comprising about 1 mg to about 10 mg gaboxadol or a pharmaceutically acceptable salt thereof.

5. The method of claim 1 , wherein the patient is administered a composition comprising about 1 mg to about 5 mg gaboxadol or a pharmaceutically acceptable salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2019
From: DURING, MATTHEW
To: OVID THERAPEUTICS INC.
Reel/Frame 049505/0058 →
Continuity (4)
Continuation 16013500 · Jun 20, 2018
Continuation 15673737 · Aug 10, 2017
Provisional Application 62490293 · Apr 26, 2017
Provisional Application 62373589 · Aug 11, 2016
Cited By (1)
US 1,059,370